2/27/24 19:54 | 2/27/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.7322 | 0 | -3 | -3 | 102 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.5000 | 0 | -4 | -4 | 99 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.45 | 0 | -4 | -4 | 96 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.42 | 0 | -4 | -4 | 92 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -6 | 1.68 | 0 | -4 | -4 | 89 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -10 | 2.72 | 0 | -4 | -4 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -15 | 4.02 | 0 | -4 | -4 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -54 | 4.01 | 0 | -13 | -2 | 631 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -25 | 1.90 | 0 | -13 | -2 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -7 | 1.90 | 0 | -4 | -4 | 79 | D | | | | | | | | | | | | | | |
3/1/22 21:13 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -41 | 2.78 | 0 | -15 | -2 | 607 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -7 | 2.78 | 0 | -2 | -6 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -11 | 2.78 | 0 | -4 | -5 | 76 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.dm | -22 | 4.81 | 0 | -5 | -11 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.dm | -36 | 4.81 | 0 | -8 | -9 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:46 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.dm | -133 | 4.81 | 0 | -28 | -4 | 590 | D | | | | | | | | | | | | | | |